A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/14 (2006.01) A61P 17/00 (2006.01) A61P 31/04 (2006.01)
Patent
CA 2736860
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described.
L'invention porte sur des glycopeptides antibiotiques tels que l'oritavancine, qui présentent une activité significative contre un large éventail de bactéries, et sur des méthodes de traitement, de prophylaxie et de prévention d'infections et de maladies bactériennes chez l'animal dont l'homme utilisant une dose unique d'oritavancine pendant la durée de la thérapie.
Etienne Pierre
Lehoux Dario
Moeck Gregory
Parr Thomas R.
Gowling Lafleur Henderson Llp
Targanta Therapeutics Corp.
LandOfFree
Methods of treatment using single doses of oritavancin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment using single doses of oritavancin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using single doses of oritavancin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916551